Effects of Salvinorin A in Healthy Controls

Conditions

Healthy

Trial Phase

Phase 1

Trial Purpose and Description

Trial Purpose


Participation Guidelines

Age:
18 Years - 45 Years
Gender:
Both

Eligibility Criteria


Inclusion Criteria:

-Previous exposure to inhaled Salvinorin A (SA).
Sponsor:
National Alliance for Research on Schizophrenia and Depression
Yale University
Dates:
January 2009
Last Updated:
September 12, 2013
Study HIC#:
0707002884

Clinicaltrials.gov ID: NCT00700596